Another possible mechanism is the non-enzymatic glycation of angiotensin-converting enzyme 2 (ACE2) (13), since its expression has been observed to decrease in patients with DM and it could predispose to greater severity and death in respiratory diseases (11) such as COVID-19 (13, 14). Here, ACE2 is linked to COVID-19.